丙型肝炎病毒(hepatitis C virus,HCV)感染可引起慢性肝炎,最终导致肝衰竭、肝硬化和肝癌。目前尚无有效的HCV疫苗,其治疗仍以标准化方案聚乙二醇干扰素联合利巴韦林为主。其疗程长,费用高,副作用大,且不能从根本上解决慢性尤其是难治...
详细信息
丙型肝炎病毒(hepatitis C virus,HCV)感染可引起慢性肝炎,最终导致肝衰竭、肝硬化和肝癌。目前尚无有效的HCV疫苗,其治疗仍以标准化方案聚乙二醇干扰素联合利巴韦林为主。其疗程长,费用高,副作用大,且不能从根本上解决慢性尤其是难治性丙肝的治疗难题,因此,HCV疫苗的研究迫在眉睫。本文就HCV疫苗临床试验的研究进展作一综述。
Objective To study the mechanism and the exact target of Schizandronic acid(SZA)and Anwuweizic acid(AWA),two members of tetracyclic triterpenoid acid family,on hepatitis C virus(HCV).Methods The two compounds were scr...
详细信息
Objective To study the mechanism and the exact target of Schizandronic acid(SZA)and Anwuweizic acid(AWA),two members of tetracyclic triterpenoid acid family,on hepatitis C virus(HCV).Methods The two compounds were screened out through cell culture-derived HCV(HCVcc)from hundreds of natural pharmaceutical plants,and were confirmed to have antiviral activities against
暂无评论